Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Hyman

Showing results (161-170 of 174) with videos related to

Pageof 18
Sort By:
Cancer Cell|September 12, 2018
The Genomic Landscape of Endocrine-Resistant Advanced Breast CancersPedram Razavi, Matthew T Chang, Guotai Xu, et al.
Nature Medicine|November 27, 2019
High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variantsPedram Razavi, Bob T Li, David N Brown, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2018
Microsatellite Instability Is Associated With the Presence of Lynch Syndrome Pan-CancerAlicia Latham, Preethi Srinivasan, Yelena Kemel, et al.
JCO Precision Oncology|September 12, 2017
OncoKB: A Precision Oncology Knowledge BaseDebyani Chakravarty, Jianjiong Gao, Sarah M Phillips, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2019
Genomic Correlates of Disease Progression and Treatment Response in Prospectively Characterized GliomasPhilip Jonsson, Andrew L Lin, Robert J Young, et al.
Nature|February 14, 2019
Author Correction: HER kinase inhibition in patients with HER2- and HER3-mutant cancersDavid M Hyman, Sarina A Piha-Paul, Helen Won, et al.
Nature|February 9, 2018
HER kinase inhibition in patients with HER2- and HER3-mutant cancersDavid M Hyman, Sarina A Piha-Paul, Helen Won, et al.
JAMA|September 6, 2017
Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline TestingDiana Mandelker, Liying Zhang, Yelena Kemel, et al.
Cancer Discovery|November 15, 2015
Diverse and Targetable Kinase Alterations Drive Histiocytic NeoplasmsEli L Diamond, Benjamin H Durham, Julien Haroche, et al.
Cancer Discovery|March 28, 2020
HER2-Mediated Internalization of Cytotoxic Agents in <i>ERBB2</i> Amplified or Mutant Lung CancersBob T Li, Flavia Michelini, Sandra Misale, et al.
Pageof 18

Showing results (161-170 of 174) with videos related to

Sort By:
Pageof 18
Cancer Cell|September 12, 2018
The Genomic Landscape of Endocrine-Resistant Advanced Breast CancersPedram Razavi, Matthew T Chang, Guotai Xu, et al.
Nature Medicine|November 27, 2019
High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variantsPedram Razavi, Bob T Li, David N Brown, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2018
Microsatellite Instability Is Associated With the Presence of Lynch Syndrome Pan-CancerAlicia Latham, Preethi Srinivasan, Yelena Kemel, et al.
JCO Precision Oncology|September 12, 2017
OncoKB: A Precision Oncology Knowledge BaseDebyani Chakravarty, Jianjiong Gao, Sarah M Phillips, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2019
Genomic Correlates of Disease Progression and Treatment Response in Prospectively Characterized GliomasPhilip Jonsson, Andrew L Lin, Robert J Young, et al.
Nature|February 14, 2019
Author Correction: HER kinase inhibition in patients with HER2- and HER3-mutant cancersDavid M Hyman, Sarina A Piha-Paul, Helen Won, et al.
Nature|February 9, 2018
HER kinase inhibition in patients with HER2- and HER3-mutant cancersDavid M Hyman, Sarina A Piha-Paul, Helen Won, et al.
JAMA|September 6, 2017
Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline TestingDiana Mandelker, Liying Zhang, Yelena Kemel, et al.
Cancer Discovery|November 15, 2015
Diverse and Targetable Kinase Alterations Drive Histiocytic NeoplasmsEli L Diamond, Benjamin H Durham, Julien Haroche, et al.
Cancer Discovery|March 28, 2020
HER2-Mediated Internalization of Cytotoxic Agents in <i>ERBB2</i> Amplified or Mutant Lung CancersBob T Li, Flavia Michelini, Sandra Misale, et al.
Pageof 18